Matinas BioPharma
MTNB
MTNB
55 hedge funds and large institutions have $18M invested in Matinas BioPharma in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+5
Holders Change %
+10%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SPIA
51
Steward Partners Investment Advisory
New York
| $2K | – | – | – |
|
|
HFM
52
Hartford Financial Management
Hartford,
Connecticut
| $2K | – | – | – |
|
53
Bank of America
Charlotte,
North Carolina
| $1K | -$1.21K | -40 | -55% |
|
|
IIA
54
IPG Investment Advisors
San Diego,
California
| – | -$45K | -1,148 | Closed |
|
|
SBWIC
55
Schaper Benz & Wise Investment Counsel
Neenah,
Wisconsin
| – | -$11K | -290 | Closed |
|
|
VVP
56
Venture Visionary Partners
Sylvania,
Ohio
| – | -$3.8K | -96 | Closed |
|
|
GWMIA
57
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
| – | -$1K | -13 | Closed |
|